Wei-wu He - Net Worth and Insider Trading
Wei-wu He Net Worth
The estimated net worth of Wei-wu He is at least $6 Million dollars as of 2024-06-05. Wei-wu He is the Chairman and CEO, 10% Owner of CASI Pharmaceuticals Inc and owns about 1,741,894 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $6 Million. Details can be seen in Wei-wu He's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wei-wu He has not made any transactions after 2022-06-15 and currently still holds the listed stock(s).
Transaction Summary of Wei-wu He
Wei-wu He Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wei-wu He owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .
Click here to see the complete history of Wei-wu He’s form 4 insider trades.
Insider Ownership Summary of Wei-wu He
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2022-06-15 | director & 10 percent owner & Chairman and CEO |
Wei-wu He Latest Holdings Summary
Wei-wu He currently owns a total of 1 stock. Wei-wu He owns 1,741,894 shares of CASI Pharmaceuticals Inc (CASI) as of June 15, 2022, with a value of $6 Million.
Latest Holdings of Wei-wu He
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals Inc | 2022-06-15 | 1,741,894 | 3.57 | 6,218,562 |
Holding Weightings of Wei-wu He
Wei-wu He Form 4 Trading Tracker
According to the SEC Form 4 filings, Wei-wu He has made a total of 13 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years, including 13 buys and 0 sells. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 88,154 shares on June 15, 2022, which cost Wei-wu He around $272,396.
Insider Trading History of Wei-wu He
- 1
Wei-wu He Trading Performance
GuruFocus tracks the stock performance after each of Wei-wu He's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wei-wu He is 22.58%. GuruFocus also compares Wei-wu He's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wei-wu He within 3 months outperforms 11 times out of 19 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wei-wu He's insider trading performs compared to the benchmark.
Performance of Wei-wu He
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.66 | | | | | |
| Relative Return to S&P 500(%) | 11.67 | | | | | |
Wei-wu He Ownership Network
Wei-wu He Owned Company Details
What does CASI Pharmaceuticals Inc do?
Who are the key executives at CASI Pharmaceuticals Inc?
Wei-wu He is the director & 10 percent owner & Chairman and CEO of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include Chief Financial Officer Weihao Xu , President Larry Zhang , and 10 percent owner Wealth Strategy Holding Ltd .
CASI Pharmaceuticals Inc (CASI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.
CASI Pharmaceuticals Inc Insider Transactions
Wei-wu He Mailing Address
Above is the net worth, insider trading, and ownership report for Wei-wu He. You might contact Wei-wu He via mailing address: Entremed, Inc., 9640 Medical Center Drive, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
